Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at Gabelli issued their FY2021 earnings per share (EPS) estimates for Henry Schein in a research note issued on Tuesday. Gabelli analyst K. Kedra anticipates that the firm will post earnings per share of $11.30 for the year. Gabelli currently has a “Buy” rating and a $208.00 price target on the stock.
Several other brokerages have also recently issued reports on HSIC. Zacks Investment Research cut Henry Schein from a “hold” rating to a “sell” rating in a research note on Tuesday, September 20th. Goldman Sachs Group, Inc. (The) upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price objective on the stock in a research note on Tuesday, October 11th. J P Morgan Chase & Co reiterated a “hold” rating and issued a $163.00 price objective on shares of Henry Schein in a research note on Thursday, November 3rd. Robert W. Baird cut Henry Schein from an “outperform” rating to a “neutral” rating and reduced their price objective for the company from $176.00 to $164.00 in a research note on Friday, October 14th. Finally, Leerink Swann reiterated a “hold” rating on shares of Henry Schein in a research note on Thursday, November 3rd. One analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $178.28.
Henry Schein (NASDAQ:HSIC) traded down 0.21% during mid-day trading on Wednesday, reaching $157.76. The company’s stock had a trading volume of 614,091 shares. Henry Schein has a one year low of $142.64 and a one year high of $183.00. The firm has a market cap of $12.70 billion, a PE ratio of 26.20 and a beta of 1.04. The stock’s 50 day moving average is $152.40 and its 200 day moving average is $162.18.
Henry Schein (NASDAQ:HSIC) last announced its earnings results on Wednesday, November 2nd. The company reported $1.68 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.65 by $0.03. Henry Schein had a return on equity of 18.15% and a net margin of 4.40%. The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.88 billion. During the same period in the previous year, the business earned $1.55 EPS. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis.
In other news, Director Kurt P. Kuehn bought 1,000 shares of the business’s stock in a transaction dated Monday, December 12th. The shares were acquired at an average price of $151.41 per share, for a total transaction of $151,410.00. Following the completion of the transaction, the director now owns 2,039 shares of the company’s stock, valued at $308,724.99. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Mark E. Mlotek sold 2,417 shares of Henry Schein stock in a transaction dated Thursday, November 3rd. The stock was sold at an average price of $155.19, for a total value of $375,094.23. Following the sale, the executive vice president now owns 40,456 shares in the company, valued at approximately $6,278,366.64. The disclosure for this sale can be found here. Insiders own 1.27% of the company’s stock.
Several hedge funds have recently bought and sold shares of HSIC. Advisor Group Inc. bought a new position in Henry Schein during the second quarter worth about $106,000. FineMark National Bank & Trust raised its position in Henry Schein by 3.3% in the third quarter. FineMark National Bank & Trust now owns 651 shares of the company’s stock worth $106,000 after buying an additional 21 shares in the last quarter. Global X Management Co. LLC raised its position in Henry Schein by 18.7% in the second quarter. Global X Management Co. LLC now owns 661 shares of the company’s stock worth $117,000 after buying an additional 104 shares in the last quarter. Quadrant Capital Group LLC raised its position in Henry Schein by 0.4% in the second quarter. Quadrant Capital Group LLC now owns 742 shares of the company’s stock worth $128,000 after buying an additional 3 shares in the last quarter. Finally, Van ECK Associates Corp raised its position in Henry Schein by 29.1% in the second quarter. Van ECK Associates Corp now owns 727 shares of the company’s stock worth $129,000 after buying an additional 164 shares in the last quarter. Institutional investors and hedge funds own 91.29% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.